ATE548349T1 - In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung - Google Patents

In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung

Info

Publication number
ATE548349T1
ATE548349T1 AT08845678T AT08845678T ATE548349T1 AT E548349 T1 ATE548349 T1 AT E548349T1 AT 08845678 T AT08845678 T AT 08845678T AT 08845678 T AT08845678 T AT 08845678T AT E548349 T1 ATE548349 T1 AT E548349T1
Authority
AT
Austria
Prior art keywords
production
pyridine derivatives
therapeutic application
disubstituted indol
indol
Prior art date
Application number
AT08845678T
Other languages
English (en)
Inventor
Marco Baroni
Letizia Puleo
Original Assignee
Sanofi Sa
Letizia Puleo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Letizia Puleo filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE548349T1 publication Critical patent/ATE548349T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
AT08845678T 2007-08-16 2008-08-14 In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung ATE548349T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705858A FR2920023B1 (fr) 2007-08-16 2007-08-16 Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
PCT/FR2008/001190 WO2009056707A2 (fr) 2007-08-16 2008-08-14 Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
ATE548349T1 true ATE548349T1 (de) 2012-03-15

Family

ID=39197313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08845678T ATE548349T1 (de) 2007-08-16 2008-08-14 In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung

Country Status (42)

Country Link
US (2) US20100210662A1 (de)
EP (1) EP2188253B8 (de)
JP (1) JP5685440B2 (de)
KR (1) KR20100051812A (de)
CN (1) CN103443076B (de)
AR (1) AR067937A1 (de)
AT (1) ATE548349T1 (de)
AU (1) AU2008320718B2 (de)
BR (1) BRPI0815171A2 (de)
CA (1) CA2696237C (de)
CO (1) CO6251363A2 (de)
CR (1) CR11273A (de)
CY (1) CY1112809T1 (de)
DK (1) DK2188253T3 (de)
DO (1) DOP2010000050A (de)
EA (1) EA019486B1 (de)
EC (1) ECSP109961A (de)
ES (1) ES2384080T3 (de)
FR (1) FR2920023B1 (de)
GT (1) GT201000032A (de)
HN (1) HN2010000330A (de)
HR (1) HRP20120466T1 (de)
IL (1) IL203956A (de)
JO (1) JO2749B1 (de)
MA (1) MA31742B1 (de)
ME (1) ME00979B (de)
MX (1) MX2010001851A (de)
MY (1) MY149649A (de)
NI (1) NI201000023A (de)
NZ (1) NZ583317A (de)
PA (1) PA8793101A1 (de)
PE (1) PE20090988A1 (de)
PL (1) PL2188253T3 (de)
PT (1) PT2188253E (de)
RS (1) RS52321B (de)
SI (1) SI2188253T1 (de)
TN (1) TN2010000025A1 (de)
TW (1) TWI432423B (de)
UA (1) UA101162C2 (de)
UY (1) UY31297A1 (de)
WO (1) WO2009056707A2 (de)
ZA (1) ZA201001085B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
FR2941947B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
FR2941946B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique
AU2010212867B2 (en) 2009-02-13 2013-05-16 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a SGLT2 inhibitor, a DPP-IV inhibitor and optionally a further antidiabetic agent and uses thereof
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
EP2567959B1 (de) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
CN108658836B (zh) * 2018-05-15 2021-04-20 宁波大学 一种3-取代-3-叠氮基吲哚-2-酮类化合物的制备方法
EP3912625A1 (de) * 2020-05-20 2021-11-24 Kaerus Bioscience Limited Neuartige maxi-k-kaliumkanal-öffner zur behandlung von mit fragilem x assoziierten erkrankungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714378B1 (fr) * 1993-12-24 1996-03-15 Sanofi Sa Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
US6576656B1 (en) * 1998-08-20 2003-06-10 Sumitomo Pharmaceuticals Co., Ltd. Oxindole derivative
FR2827604B1 (fr) * 2001-07-17 2003-09-19 Sanofi Synthelabo Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
WO2005035498A1 (ja) * 2003-10-08 2005-04-21 Dainippon Sumitomo Pharma Co., Ltd. 含窒素二環性化合物の摂食調節剤としての用途

Also Published As

Publication number Publication date
HN2010000330A (es) 2012-03-19
RS52321B (en) 2012-12-31
CN103443076B (zh) 2016-06-22
CY1112809T1 (el) 2016-02-10
MY149649A (en) 2013-09-30
CA2696237C (fr) 2016-07-05
ZA201001085B (en) 2011-04-28
PT2188253E (pt) 2012-05-11
JP5685440B2 (ja) 2015-03-18
US20110118280A1 (en) 2011-05-19
DK2188253T3 (da) 2012-07-02
EA201070281A1 (ru) 2010-08-30
ME00979B (me) 2012-06-20
HRP20120466T1 (hr) 2012-07-31
AU2008320718B2 (en) 2013-09-19
DOP2010000050A (es) 2010-04-15
JO2749B1 (en) 2014-03-15
NZ583317A (en) 2011-11-25
CN103443076A (zh) 2013-12-11
TN2010000025A1 (fr) 2011-09-26
UY31297A1 (es) 2009-03-31
KR20100051812A (ko) 2010-05-18
JP2010536736A (ja) 2010-12-02
EP2188253B1 (de) 2012-03-07
WO2009056707A8 (fr) 2010-03-18
EP2188253B8 (de) 2012-04-11
PE20090988A1 (es) 2009-08-14
US8202871B2 (en) 2012-06-19
IL203956A (en) 2014-06-30
CA2696237A1 (fr) 2009-05-07
FR2920023A1 (fr) 2009-02-20
WO2009056707A3 (fr) 2009-10-01
SI2188253T1 (sl) 2012-09-28
FR2920023B1 (fr) 2013-02-08
UA101162C2 (ru) 2013-03-11
CO6251363A2 (es) 2011-02-21
WO2009056707A2 (fr) 2009-05-07
TW200914438A (en) 2009-04-01
GT201000032A (es) 2012-03-12
EA019486B1 (ru) 2014-04-30
ECSP109961A (es) 2010-03-31
PL2188253T3 (pl) 2012-08-31
PA8793101A1 (es) 2009-01-23
AR067937A1 (es) 2009-10-28
NI201000023A (es) 2010-03-11
EP2188253A2 (de) 2010-05-26
TWI432423B (zh) 2014-04-01
US20100210662A1 (en) 2010-08-19
MA31742B1 (fr) 2010-10-01
AU2008320718A1 (en) 2009-05-07
BRPI0815171A2 (pt) 2015-03-31
MX2010001851A (es) 2010-03-11
ES2384080T3 (es) 2012-06-29
CR11273A (es) 2010-07-16

Similar Documents

Publication Publication Date Title
ATE372998T1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE548349T1 (de) In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
DE602005006815D1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
ATE453637T1 (de) N-(aminoheteroaryl)-1h-indol-2-carboxamid- derivate sowie deren herstellung und therapeutische anwendung
ATE461930T1 (de) Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung
DE502005002105D1 (de) 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln
ATE423119T1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
DE602005019743D1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
DE602005026964D1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
ATE475661T1 (de) Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
ATE412635T1 (de) Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung
ATE540023T1 (de) Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
DE602005003246D1 (de) Polyalkyleniminderivat, dessen Herstellungsverfahren und Verwendungen
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
DE602006015675D1 (de) 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung
ATE520654T1 (de) Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE499351T1 (de) Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung
DK2194968T3 (da) Lerbaseret, aromatiseret og terapeutisk sammensætning
ATE448211T1 (de) 1,2,4-triazinderivate, ihre herstellung und ihre verwendung in der humantherapie
ATE529426T1 (de) N-phenyl-imidazo(1,2-a)pyridincarboxamid- verbindungen, ihre herstellung sowie ihre therapeutische anwendung
ATE524468T1 (de) Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung
DE602006008971D1 (de) N-ä(4,5-diphenylpyrimidin-2-yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung